172 countries and multiple candidate vaccines engaged in COVID-19 vaccine Global Access Facility
On Aug. 24, 2020, the World Heath Organization (WHO) reported that 172 economies were engaged in discussions to…
On Aug. 24, 2020, the World Heath Organization (WHO) reported that 172 economies were engaged in discussions to…
On Aug. 24, 2020, Hong Kong University researchers reported that a 33-year-old man in Hong Kong had been…
On Aug. 24, 2020, the combination of hydroxychloroquine and azithromycin has been linked to significant cardiovascular risks, including…
On Aug. 24, 2020, a published study led by the Universities of Oxford and Birmingham found that, compared…
On Aug. 24 2020, NantKwest and ImmunityBio announced an agreement to jointly develop, manufacture, market, and commercialize therapeutics…
On Aug. 24, 2020, Innovation Pharma reported receiving additional data from a U.S. Regional Biocontainment Laboratory (RBL) based…
On Aug. 24, 2020, humans are not the only species facing a potential threat from SARS-CoV-2, the novel…
On Aug. 24, 2020, Novavax announced that the first volunteers were enrolled in the Phase 2 portion of…
On Aug. 24, 2020, the Quest Diagnostics Foundation announced a wide-ranging initiative to address and reduce health disparities…
On Aug. 24, 2020, Catalent announced that it had contracted to provide drug substance manufacturing to AstraZeneca for…
On Aug. 24, 2020, AXIM Biotechnologies announced that it had signed an exclusive limited licensing, manufacturing and distribution…
On Aug. 24, 2020,Trevena announced that Imperial College London (ICL) had initiated a proof-of-concept study for TRV027 in…
On Aug. 24, 2020, XBiotech announced that the FDA issued an emergency use authorization (EUA) for COVID-19 Convalescent…
On Aug. 23, 2020, the FDA issued an emergency use authorization (EUA) for investigational convalescent plasma for the…
On Aug. 23, 2020, the Mayo Clinic announced that with the FDA Emergency Use Authorization of convalescent plasma,…
On Aug. 21, 2020, the CDC published Immunization Practices Advisory Committee (ACIP) 2020-21 influenza vaccination recommendations. Routine annual…
On Aug. 21, 2020, JAMA reported that hospitalized patients with moderate COVID-19 randomized to a 5-day course of…
On Aug. 21, 2020, research by the University of Minnesota and the University of Washington found that every…
On Aug. 20, 2020, CureVac and the European Commission (EC) concluded exploratory talks outlining an Advanced Purchase Agreement…
On Aug. 20, 2020, Sorrento Therapeutics and SmartPharm Therapeutics announced the signing of a merger agreement under which…
On Aug. 20, 2020, GT Biopharma and Cytovance announced a collaboration agreement whereby Cytovance will providing drug development…
On Aug. 20, 2020, the La Jolla Institute for Immunology (LJI) announced that Erica Ollmann Saphire, Ph.D. had…
On Aug. 20, 2020, Oragenics and Avid Bioservices announced a process development and drug substance manufacturing agreement. Avid…
On Aug. 20, 2020, in the most comprehensive study of COVID-19 pediatric patients to date, Harvard Medical School…
On Aug. 20, 2020, OpGen announced that its subsidiary Curetis GmbH had obtained the CE mark certification in…
On Aug. 20, 2020, Pfizer and BioNTech shared additional Phase 1 safety and immunogenicity data from their U.S….
On Aug. 19, 2020, JAMA reported that to date, SARS-CoV-2 has not been isolated from breast milk, and…
On Aug. 19, 2020, the National Institutes of Health (NIH) began requiring a small nonprofit research organization to…
On Aug. 19, 2020, the CDC released a new study that specifically examines how COVID-19 is affecting American…
On Aug. 19, 2020, Sorrento announced that it had filed an investigational new drug application (IND) for COVI-GUARD…